Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain BHP Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Commodity Conditions CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline OPHC Q1 2026 Earnings EPS Misses Estimates by 1475 RILYN Q1 2024 Earnings Loss Per Share of 171 Amidst Limited Financial Disclosures Editas Medicine Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment